By Dr. Moxit Shah, DM Endocrinologist
Vishuddha Endocrine Clinic, Ahmedabad
Sitagliptin, Vildagliptin and Teneligliptin are among the most commonly prescribed Diabetes tablets in India.
They belong to a group called DPP-4 Inhibitors, often simply called “gliptins”.
They are generally well tolerated, weight-neutral and carry a low risk of Hypoglycemia when used alone. But they also have specific precautions, and they are not the right choice for everyone. This guide explains what patients should know.
What are DPP-4 Inhibitors?
DPP-4 Inhibitors are oral medicines used mainly in Type 2 Diabetes. Common ones in India include:
- Sitagliptin
- Vildagliptin
- Teneligliptin
- Linagliptin
- Saxagliptin
The American Diabetes Association (ADA) Standards of Care describe DPP-4 Inhibitors as having an intermediate glucose-lowering effect, a neutral effect on weight and a low risk of Hypoglycemia.
How do DPP-4 Inhibitors work?
After a meal, the gut releases natural hormones called incretins. DPP-4 Inhibitors stop these hormones from being broken down too quickly, so they:
- Increase Insulin release when blood glucose is high
- Reduce glucagon release
- Help lower blood glucose after meals
Because they work mainly when glucose is raised, Hypoglycemia is uncommon when they are used alone. This is different from Sulfonylureas, which can release Insulin even when glucose is not high.
Do DPP-4 Inhibitors cause weight gain?
No.
They are considered weight-neutral. But “weight-neutral” does not mean “weight-loss medicine”. They are not intended to produce significant weight loss.
Many patients tell us:
“I wanted a tablet that would not make me gain weight or cause frequent low sugar.”
Do DPP-4 Inhibitors cause Hypoglycemia?
Usually not, when used alone.
The risk increases when they are combined with medicines that can themselves cause low sugar, particularly Sulfonylureas and Insulin. Know the warning signs in our guide to Hypoglycemia and the 15-15 rule.
Can DPP-4 Inhibitors be taken with Metformin?
Yes.
This is one of the most common combinations in Type 2 Diabetes, often as a single combined tablet.
Metformin → reduces glucose release from the liver and improves Insulin sensitivity
DPP-4 Inhibitor → works through the incretin pathway after meals
Whether this combination suits you depends on your HbA1c, kidney function, other medicines, cost and treatment goals. See our complete guide to Diabetes medicines.
Can I take a DPP-4 Inhibitor with a GLP-1 medicine?
No.
Both act on the incretin pathway. The ADA recommends against combining a DPP-4 Inhibitor with a GLP-1 medicine such as Semaglutide or Liraglutide, because the combination does not add meaningful glucose-lowering benefit.
If you are starting a GLP-1 medicine, your doctor will usually stop the DPP-4 Inhibitor. Read GLP-1 agonists explained.
Is a DPP-4 Inhibitor better than a GLP-1 medicine?
Not necessarily. They are different classes with different strengths.
- DPP-4 Inhibitors: oral, weight-neutral, modest glucose lowering, generally well tolerated
- GLP-1 medicines: usually injections, stronger glucose lowering, significant weight loss, and cardiovascular and kidney benefits with certain agents in suitable patients
The better question is: which treatment fits this patient’s glucose levels, weight, kidney function, heart health, preferences and budget?
What side effects can DPP-4 Inhibitors cause?
Most people tolerate them well. Possible side effects include:
- Headache
- Cold-like symptoms (Nasopharyngitis)
- Mild stomach upset
- Joint pain
Joint pain
Uncommon, but severe or persistent joint pain has been reported. Tell your doctor if it develops after starting the medicine.
Pancreatitis
Pancreatitis has rarely been reported, although a clear causal link has not been established. Many doctors avoid incretin-based medicines in people with a history of Pancreatitis.
Seek urgent care for severe, persistent upper abdominal pain, especially pain spreading to the back, with or without vomiting.
Skin blistering (Bullous Pemphigoid)
Rarely, DPP-4 Inhibitors have been linked with Bullous Pemphigoid, which causes itchy skin and blisters. If unexplained blisters appear, see your doctor. The medicine is usually stopped if this is suspected.
Medicine-specific precautions
- Vildagliptin: liver function tests are usually checked, and it is avoided in significant liver disease
- Saxagliptin: caution in people with Heart Failure, or at risk of it
- Teneligliptin: caution in significant liver disease and in people with heart-rhythm (QT) problems
Do DPP-4 Inhibitors need kidney dose adjustment?
Some do.
Sitagliptin, Saxagliptin and Vildagliptin need their dose adjusted when kidney function is reduced. Linagliptin does not need kidney-based dose adjustment, which makes it a practical choice for many people with Chronic Kidney Disease.
Your doctor will check your eGFR before choosing. Read more in are Diabetes medicines harmful to the kidneys? and Diabetes and kidney health.
| Medicine | Weight effect | Hypoglycemia risk alone | Kidney dose adjustment |
|---|---|---|---|
| Sitagliptin | Neutral | Low | Yes |
| Vildagliptin | Neutral | Low | Yes |
| Teneligliptin | Neutral | Low | Discuss with your doctor |
| Linagliptin | Neutral | Low | No |
| Saxagliptin | Neutral | Low | Yes |
Who should not take DPP-4 Inhibitors?
- People with Type 1 Diabetes
- Pregnant or breastfeeding women
- People who had a serious allergic reaction to a gliptin
- People with a history of Pancreatitis, in most cases
- People already on a GLP-1 medicine
People with kidney, liver or heart problems can often still use them, with the right choice of medicine and dose.
DPP-4 Inhibitor treatment in Ahmedabad
At Vishuddha Endocrine Clinic, Dr. Moxit Shah individualizes Diabetes treatment according to HbA1c, weight, kidney and liver function, heart health, other medicines, cost and patient preference. A tablet that works well for one person may not suit another.
Please do not start, stop or switch Diabetes medicines without discussing it with your treating doctor.
Frequently Asked Questions About DPP-4 Inhibitors
Do Sitagliptin or Teneligliptin cause weight gain?
No. DPP-4 Inhibitors are weight-neutral, but they are not weight-loss medicines.
Can Sitagliptin be taken with Metformin?
Yes. It is a common combination, when appropriate for the individual.
Can I take Sitagliptin with Semaglutide?
Generally no. The ADA recommends against combining DPP-4 Inhibitors with GLP-1 medicines.
Is low sugar common with DPP-4 Inhibitors?
No, when used alone. The risk rises with Insulin or Sulfonylureas.
Which DPP-4 Inhibitor is best in kidney disease?
It depends on your kidney function. Linagliptin needs no kidney dose adjustment; others need adjusted doses.
Final Takeaway
DPP-4 Inhibitors can be a simple, well-tolerated part of Type 2 Diabetes treatment, when chosen for the right person.
The right gliptin + kidney-based dosing + no combination with GLP-1 + awareness of rare side effects + healthy lifestyle + regular HbA1c monitoring.
If you have questions about Sitagliptin, Vildagliptin, Teneligliptin or Linagliptin, consult an endocrinologist before changing anything.
Dr. Moxit Shah
DM Endocrinologist
Vishuddha Endocrine Clinic, Ahmedabad
📞 +91 99799 92797
📍 Elite Magnum, Bhuyangdev Cross Road, Ahmedabad
🌐 endocrinologistinahmedabad.com
This article is for educational purposes only and does not replace an individual medical consultation. Prescription medicines should be started, adjusted or stopped only under the supervision of a qualified healthcare professional.
